Neuropsychiatric Symptoms Induced by Oxytocin Injection

doi:10.19803/j.1672-8629.2021.02.15

Abstract

Abstract: Objective To analyze the risk of neuropsychiatric symptoms induced by oxytocin injection. Methods A total of 481 cases of suspected ADRs caused by oxytocin injection collected by the ADR monitoring database of Shandong Province between 2018 and 2019 and by Weifang between 2013 and 2017 were analyzed. Results Monitoring data, domestic and foreign literature showed that neuropsychiatric symptoms were a new risk of serious adverse reactions induced by oxytocin injection. Conclusion The safety monitoring and risk control of oxytocin injection should be strengthened, and the product specifications should be updated quickly to promote the safe and rational use of drugs in clinical practice.

Key words: oxytocin injection, neuropsychiatric symptoms, adverse drug reaction

CLC Number:

R984R969.3

BAI Junsong, CAO Jianying, Li Jia. Neuropsychiatric Symptoms Induced by Oxytocin Injection[J]. Chinese Journal of Pharmacovigilance, 2021, 18(2): 170-173.

References

[1] Sundin C, Mazac L, Ellis K, et al.Implementation of an oxytocin checklist to improve clinical outcomes[J]. MCN. The American Journal of Maternal Child Nursing,2018, 43(3): 1.
[2] Liang XL, Hu DM, Sun YH.Serious adverse drug reactions induced by oxytocin injection: an analysis of 84 cases[J]. Anhui Medical and Pharmaceutical Journal(安徽医药), 2016, 20(10): 1993-1995.
[3] Chen X, Zhang GB, Long LP, et al.Literature analysis of 52 cases of severe adverse drug reaction induced by oxytocin injection[J]. China Pharmaceuticals(中国药业), 2016,25(22): 13-16.
[4] Song XY, Xiao C.Domestic case analysis of adverse drug reactions to oxytocin injection[J].World Clinical Drugs(世界临床药物),2015,36(7): 476-479.
[5] Chen JY, Xu XH. A case of postpartum hypersensitivity to oxytocin in term pregnancy[J]. Zhejiang Practical Medicine(浙江实用医学), 2015, 2(20): 52,58.
[6] FDA Drugs.FDA national drug code decabeose [EB/OL]. [2019-12-01].https://www.drugfuture.com/fda-ndc/detail.aspx? ProductID=42023-130_.
[7] Yang BF, Su DF.Pharmacology (药理学) [M]. 8th ed. Beijing: People's Medical Publishing House, 2014:316.
[8] Sean C Sweetman Martindale The Complete Drug Reference (The 35th edition)(马丁代尔药物大典原著第35 版)[M]Sean C Sweetman Martindale The Complete Drug Reference (The 35th edition)(马丁代尔药物大典原著第35 版)[M]. Chemical Industry Press (Biology Medical Publishing Branch),2009:1445-1446.
[9] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People's Republic of China:Part One. The 2015 edition(中华人民共和国药典:一部)[M]. Beijing: China Medical Science and Technology Press, 2015: 1512.
[10] Wang YX, Jin WH, Zong WF, et al.Studies on high molecular weight substances and allergic response of oxytocin injection[J]. Chinese Journal of Biochemical and Pharmaceuticals(中国生化药物杂志), 2015, 1(35): 85-88.
[11] Liu CL, Xia DS, Tian CH.Anaphylactic shock induced by oxytocin injection in 1 case[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2015, 12(9): 570-572.
[12] Su G, Li MM, Liu WQ, et al.Diarrhea caused by oxytocin in 1 case[J]. Chinese Journal of Modern Applied Pharmacy(中国现代应用药学), 2013, 30(11):1268-1269.
[13] Knox GE.Aggregate analysis of oxytocin incidents[J]. Alta RN, 2014,69(9):30-32.
[14] Chen JG, Lu YH, Huang Q, et al.Research advances in the preparation and quality control of oxytocin[J]. Chinese Journal of Biochemical and Pharmaceuticals(中国生化药物杂志), 2012, 33(5):698-700.
[15] Yang CY, Wang LH, Liu Y.The treatment of hypersensitivity induced by oxytocin in cesarean section[J]. Journal of Clinical Medical Literature(临床医药文献杂志),2017, 4(78):15409.
[16] Huang GH, Du HR, Gong L.Analysis on global research trends of pharmacovigilance in recent five years and its implications for China[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(5):268-275.
[17] Huang Q, Lu YH, Shi QS, et al.HPLC determination of oxytocin injection and its related substances[J]. Chinese Journal of Pharmaceutical Analysis(药物分析杂志), 2011,31(10):1856-1861.
[18] Hou YF, Song HB, Liu HL, et al.Practice and discussion on active surveillance by China hospital pharmacovigilance system[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2019,16(4):212-214.